NSE: GRANULES | BSE: 532482

Strong Performer, Getting Expensive

Download real time

600.75 17.35 (2.97%)

Near 52W High of ₹621.10

1.8M NSE+BSE Volume

NSE 22 Dec, 2025 3:59 PM (IST)

14,578.3

Market Cap

High in industry

Beta 1Year

Very High Volatility

US FDA Approval

Granules India's arm receives US FDA approval for an ADHD drug, with a market size of $172 million See details

Granules India Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for GRANULES, BSE:532482 Granules India Ltd.

Granules India Ltd.

07 May 2016

600.75

2.97%

Pick of the Week - Granules India Ltd

Buy: Granules India Ltd.

HDFC Securities

Buy Granules India Ltd CMP at Rs. 126 and add on declines Rs. 135 - Rs. 125 for the Targets of Rs. 155 - Rs. 170

Mutual Funds have decreased holdings from 12.24% to 6.54% in Sep 2025 qtr

Granules India Ltd.

29 Apr 2016

600.75

2.97%

Granules India: Results largely in line; PAT up 48 % YoY

Buy: Granules India Ltd.

Motilal Oswal

GRAN's profit for 4QFY16 at INR 332m (up 48% YoY) was in line with our estimate. However, the operational number was 13% ahead of forecast, on the back of a better product mix and improving productivity at the plant level. EBITDA margin...

Number of FII/FPI investors decreased from 199 to 189 in Sep 2025 qtr

Granules India Ltd.

27 Apr 2016

600.75

2.97%

BP Equities Granules India Ltd Initiating Coverage

Buy: Granules India Ltd.

BP Wealth

Number of MF schemes decreased from 28 to 17 in Sep 2025 qtr

Granules India Ltd.

28 Mar 2016

600.75

2.97%

Granules India: At a strategic inflection point

Granules India Ltd.

Motilal Oswal

Kumar Saurabh (Kumar.Saurabh@MotilalOswal.com); +91 22 3982 5584 Investors are advised to refer through important disclosures made at the last page of the Research Report. Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P; Capital....

Granules India Ltd. has an average target of 632.00 from 4 brokers.

Is Granules India Ltd. worth buying?

868 Votes:

Buy 84.1%

Sell 10.14%

Hold 5.76%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf